“Health Economic Implications of Irbesartan Plus Conventional Antihypertensive Medications Versus Conventional Blood Pressure Control Alone in Patierns With Type 2 Diabetes, Hypertension, and Renal Disease in Switzerland”. 2006. Swiss Medical Weekly 136 (2122): 346-46. https://doi.org/10.57187/smw.2006.11337.